Exforge Hct
Product Images NDC 54868-6123

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Exforge Hct (NDC 54868-6123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Structural Formula (Exforge Hct 01)

Chemical structure of the active ingredients in Exforge HCT. The diagram shows molecular representations including aromatic rings, various functional groups such as esters and sulfonic acid, and substituent atoms like chlorine and nitrogen.*

FDA Label Image

Valsartan Structural Formula (Exforge Hct 02)

Chemical structure of the active ingredient in Exforge HCT, showing the molecular arrangement with labeled rings and side chains.*

FDA Label Image

Hydrochlorothiazide Structural Formula (Exforge Hct 03)

Chemical structure of the active ingredient for Exforge HCT, showing a chlorinated benzene ring with attached sulfonamide and amine groups.*

FDA Label Image

Figure 1: Reduction In Mean Blood Pressure At Endpoint (Exforge Hct 04)

A bar graph showing the effects of different treatments on Diastolic and Systolic Blood Pressure (BP). The x-axis differentiates Diastolic BP and Systolic BP, while the y-axis measures blood pressure changes. Bars represent four treatment groups: HCTZ/Aml 25/10, Val/HCTZ 320/25, Aml/Val 10/320, and Aml/Val/HCTZ 10/320/25, each with numeric changes labeled on each bar.*

FDA Label Image

Figure 2: Mean Sitting Diastolic Blood Pressure By Treatment And Week (Exforge Hct 05)

Line graph depicting mean sitting diastolic blood pressure (DBP) over 8 weeks for different antihypertensive treatments. The x-axis represents weeks (0 to 8), and the y-axis shows mean sitting DBP in mmHg (approximately 80 to 110). Multiple treatment groups with various dosage combinations are indicated by different markers in the legend.*

FDA Label Image

Figure 3: Mean Sitting Systolic Blood Pressure By Treatment And Week (Exforge Hct 06)

A line graph showing mean sitting systolic blood pressure (SBP) in mmHg over an 8-week period. The graph compares four treatments: Aml/HCT 10/230/25 mg, Val/HCT 320/25 mg, Aml/Val 10/320 mg, and HCTZ/Aml 25/10 mg. Each treatment is represented by a different line style and marker, illustrating changes in SBP across weeks 0 to 8.*

FDA Label Image

Figure 4: Mean Ambulatory Diastolic Blood Pressure At Endpoint By Treatment And Hour (Exforge Hct 07)

Line graph showing mean ambulatory diastolic blood pressure (DBP) over 24 hours after dosing with different treatments: Aml/Val/HCTZ 10/320/25 mg, Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, and HCTZ/Aml 25/10 mg. The x-axis represents hours after dosing, and the y-axis represents mean ambulatory DBP in mmHg.*

FDA Label Image

Figure 5: Mean Ambulatory Systolic Blood Pressure At Endpoint By Treatment And Hour (Exforge Hct 08)

A line chart showing mean ambulatory systolic blood pressure (SBP) in mmHg over 24 hours after dosing. The graph compares four different treatments: Aml/Val/HCTZ 10/320/25 mg, Val/HCTZ 320/25 mg, Aml/Val 10/320 mg, and HCTZ/Aml 25/10 mg, each represented by different line styles and markers.*

FDA Label Image

Principal Display Panel (Package Label)

Label for Exforge HCT 10/320/25 mg tablets distributed by Physicians Total Care, Inc. It includes the product name, dosage strength, lot number, expiration date (01/60), and a barcode. The label also references Novartis Pharma Stein AG, Stein, Switzerland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.